Eshelman Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
31
- Portfolio
-
11
- Exits
-
13
Eshelman Ventures General Information
Company Description
Founded in 2014, Eshelman Ventures is a venture capital firm based in Wilmington, North Carolina. The firm seeks to invest in companies operating in the healthcare sector.
Business Details
Website
www.eshelmanventures.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 5815 Oleander Drive
- Suite 105
- Wilmington, NC 28403
- United States
Eshelman Ventures Investments (31)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Paradigm Therapeutics (Biotechnology) | 06-May-2025 | Early Stage VC | Biotechnology | Clinical Trials - Phase 3 | ||
| Aravive | 25-Oct-2022 | Drug Discovery | Generating Revenue | |||
| Sapience Therapeutics | 31-May-2022 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Incyclix Bio | 31-Mar-2022 | Drug Discovery | Clinical Trials - General | |||
| Incyclix Bio | 05-Aug-2020 | Drug Discovery | Clinical Trials - General | |||
| Aravive | 08-Apr-2020 | Drug Discovery | Generating Revenue | |||
| Fountain Therapeutics | 19-Feb-2020 | Drug Discovery | Generating Revenue | |||
| Kinnate Biopharma | 12-Dec-2019 | Drug Discovery | Generating Revenue | |||
| Aruna Bio | 24-Jul-2019 | Later Stage VC | Drug Delivery | Clinical Trials - Phase 1 | ||
| Asepticys | 28-Nov-2018 | Early Stage VC | Drug Discovery | Out of Business |
Eshelman Ventures Exits (13)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Jumo Health | 15-Aug-2024 | Buyout/LBO | |
| Cellective BioTherapy | 01-Jul-2023 | ||
| Meryx | 07-Dec-2021 | ||
| Asepticys | 18-Mar-2021 | ||
| Kinnate Biopharma | 03-Dec-2020 | ||
| Innocrin Pharmaceuticals | 01-Oct-2019 | ||
| Liquidia Technologies | 26-Jul-2018 | ||
| Eyenovia | 25-Jan-2018 | ||
| Support Group International | 01-Jan-2018 | Secondary Transaction - Private | |
| Neoantigenics | 01-Sep-2017 | Out of Business |
Eshelman Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Eshelman Ventures Co-Investors (5)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Boxer Capital | 1 |
|
|
||
| Bristol-Myers Squibb |
|
|
|||
| Kingdon Capital Management |
|
|
|||
| NexPoint (Asset Management) |
|
|
|||
| RA Capital Management |
|
|
Eshelman Ventures FAQs
-
What is Eshelman Ventures?
Founded in 2014, Eshelman Ventures is a venture capital firm based in Wilmington, North Carolina.
-
When was Eshelman Ventures founded?
Eshelman Ventures was founded in 2014.
-
Where is Eshelman Ventures headquartered?
Eshelman Ventures is headquartered in Wilmington, NC.
-
How many investments has Eshelman Ventures made?
Eshelman Ventures has made 31 investments.
-
What has Eshelman Ventures invested in?
Eshelman Ventures has made numerous investments in companies like Paradigm Therapeutics (Biotechnology), Aravive, and Sapience Therapeutics within the Biotechnology and Drug Discovery industries.
-
What has Eshelman Ventures invested in recently?
Eshelman Ventures's latest investment was on 06-May-2025 in Paradigm Therapeutics (Biotechnology), a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
